Bacinschi XE - Search Results

1

Pathologic Response After Weekly Paclitaxel versus Docetaxel in Operable Breast Cancer.

Bacinschi XE, Anghel RM, Toma PI, Safta I, Ilie A, Ilie SM. Bacinschi XE, et al. Cancer Manag Res. 2020 Feb 26;12:1419-1426. doi: 10.2147/CMAR.S234527. eCollection 2020. Cancer Manag Res. 2020. PMID: 32161494 Free PMC article.

2

Current Targeted Therapies in HER2-Positive Gastric Adenocarcinoma.

Curea FG, Hebbar M, Ilie SM, Bacinschi XE, Trifanescu OG, Botnariuc I, Anghel RM. Curea FG, et al. Among authors: bacinschi xe. Cancer Biother Radiopharm. 2017 Dec;32(10):351-363. doi: 10.1089/cbr.2017.2249. Cancer Biother Radiopharm. 2017. PMID: 29265917 Review.

3

Distant Oncologic Outcome of Patients with Locally Advanced Unresectable and Metastatic Esophageal Cancer after Multimodality Treatment.

Anghel R, Constantinoiu S, Bacinschi X, Gales L, Toma RV, Trifanescu O. Anghel R, et al. Chirurgia (Bucur). 2018 Jan-Feb;113(1):116-122. doi: 10.21614/chirurgia.113.1.116. Chirurgia (Bucur). 2018. PMID: 29509538 Free article.

4

Rare Pelvic Malignant Tumors in Adults: Treatment Features and Clinical Outcome in Nonmetastatic Disease (Single Institution Experience).

Bacinschi XE, Ilie SM, Trifanescu OG, Serbanescu GL, Botnariuc I, Curea F, Orlov C, Anghel RM. Bacinschi XE, et al. Cancer Biother Radiopharm. 2019 Feb;34(1):56-66. doi: 10.1089/cbr.2018.2535. Epub 2018 Nov 28. Cancer Biother Radiopharm. 2019. PMID: 30484700

5

Potential clinically useful prognostic biomarkers in triple-negative breast cancer: preliminary results of a retrospective analysis.

Ilie SM, Bacinschi XE, Botnariuc I, Anghel RM. Ilie SM, et al. Among authors: bacinschi xe. Breast Cancer (Dove Med Press). 2018 Nov 23;10:177-194. doi: 10.2147/BCTT.S175556. eCollection 2018. Breast Cancer (Dove Med Press). 2018. PMID: 30538542 Free PMC article.

6

PREDICTIVE CIRCULATING MARKERS FOR ANTHRACYCLINE CHEMOTHERAPY IN NON-METASTATIC BREAST CANCER.

Botnariuc I, Ilie SM, Trifanescu OG, Bacinschi XE, Curea F, Anghel RM. Botnariuc I, et al. Among authors: bacinschi xe. Acta Endocrinol (Buchar). 2017 Apr-Jun;13(2):209-214. doi: 10.4183/aeb.2017.209. Acta Endocrinol (Buchar). 2017. PMID: 31149175 Free PMC article. Review.

7

Biomolecular Factors Represented by Bcl-2, p53, and Tumor-Infiltrating Lymphocytes Predict Response for Adjuvant Anthracycline Chemotherapy in Patients with Early Triple-Negative Breast Cancer.

Bacinschi XE, Zgura A, Safta I, Anghel R. Bacinschi XE, et al. Cancer Manag Res. 2020 Nov 20;12:11965-11971. doi: 10.2147/CMAR.S274104. eCollection 2020. Cancer Manag Res. 2020. PMID: 33244272 Free PMC article. Review.

8

Long-term Response After Stopping Immunotherapy in a Patient With Metastatic Renal Cancer.

Haineala B, Zgura A, Diaconu C, Mehedintu C, Bacinschi X, Anghel RM. Haineala B, et al. In Vivo. 2021 May-Jun;35(3):1805-1810. doi: 10.21873/invivo.12441. In Vivo. 2021. PMID: 33910866 Free PMC article.

9

Lung Cancer, Covid-19 Infections and Chemotherapy.

Haineala B, Zgura A, Badiu DC, Iliescu L, Anghel RM, Bacinschi XE. Haineala B, et al. Among authors: bacinschi xe. In Vivo. 2021 May-Jun;35(3):1877-1880. doi: 10.21873/invivo.12450. In Vivo. 2021. PMID: 33910875 Free PMC article.

10

Quantitative Analysis of SPECT-CT Data in Metastatic Breast Cancer Patients-The Clinical Significance.

Gherghe M, Mutuleanu MD, Stanciu AE, Irimescu I, Lazar A, Bacinschi X, Anghel RM. Gherghe M, et al. Cancers (Basel). 2022 Jan 6;14(2):273. doi: 10.3390/cancers14020273. Cancers (Basel). 2022. PMID: 35053436 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters